Adjuvant Capital launches US$300m Global Health Technology Fund for medical innovations

AFRICA – Adjuvant Capital, a life sciences investment firm focused on global health, has announced an oversubscribed US$300 million Global Health Technology Fund, focused on accelerating the development of medical innovations for historically overlooked public health challenges. Launched in 2019, Adjuvant’s debut fund will support promising new technologies for indications that the venture capital industry has largely ignored. “Billions of people around the world live under constant assault from diseases like malaria, shigella, hookworm, tuberculosis, and Lassa fever, yet Wall Street and Silicon Valley typically pay little attention to these…

Read More

54gene secures US$15m Series A funding round to scale operations

NIGERIA – 54gene, an African genomics research, services, and development startup, has closed a Series A round of US$15 million to allow it to scale operations.The startup raised a US$4.5 million seed round last year, and has now secured US$15 million in Series A capital in a round led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation. The round included participation from Raba Capital, V8 Capital, and Ingressive Capital, as well as follow-on investment from Y Combinator,…

Read More